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Background: Detecting coronary artery disease (CAD) is pivotal in etiologic assessment and management of left
ventricular (LV) systolic dysfunction. Only a limited number of studies have speciﬁcally addressed the accuracy
of coronary computed tomographic angiography (CCTA) in detection/exclusion of CAD in patients with LV
systolic dysfunction.
Methods:We included patients whowere referred for CCTA and invasive coronary angiography within 6months
of each other because of chest pain, either as part of clinical work-up in two Los Angeles medical centers from
September 2006 to May 2010 or as part of the multicenter ACCURACY trial. Sensitivity, speciﬁcity, positive and
negative predictive value, and likelihood ratios of 64 slice multidetector CCTA against coronary angiography
were calculated.
Results: Five hundred and thirty-seven patients were included: 228 (42.5%) were women, mean age was 62 ±
12 years, 82 (15.3%) had LV systolic dysfunction (deﬁned by LVEF b50%). On a patient-basedmodel, the sensitiv-
ity of CCTA to detect 50% and 70% coronary lesions was excellent across all LVEF-derived cohorts, ranging from
92% to 100%. The negative predictive value was similarly excellent, ranging from 88% to 100%. CCTA was fairly
speciﬁc for CAD, with speciﬁcity ranging from 83% to 93%, and positive predictive value from 81% to 92%.
There was no signiﬁcant between-group difference for any of the accuracy measures for detecting coronary
stenosis at 50% or 70% cutoff.
Conclusion: Sixty-four slice multidetector CCTA is a very sensitive and fairly speciﬁc noninvasive diagnostic proce-
dure for detecting coronary stenosis in patients with chest pain regardless of LV systolic function at presentation.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The most common etiology for heart failure (HF) is coronary artery
disease (CAD), towhichmore than 60% of HF is attributable [1]. A crucial
initial step when faced with new onset left ventricular (LV) dysfunction
is to determine whether the cause is ischemic or nonischemic, particu-
larly if the original presentation includes symptoms of chest pain or
other evidence of ischemia [2]. Detecting CAD is an important step in
the diagnosis of ischemic cardiomyopathy (ICM), which is deﬁned as
signiﬁcantly impaired LV function (LVEF b35%–40%) that results fromardiac computed tomographic
nvasive coronary angiography;
ability and freedom from bias of
bor-UCLA Medical Center, 1124
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land Ltd. This is an open access articlCAD. ICM is a signiﬁcant independent predictor of mortality in patients
with cardiomyopathy [3], particularly when associated with more
extensive CAD [4]. In addition to the standard management of heart
failure, the management of ICM also includes anti-ischemic medical
therapy and coronary revascularization of viable myocardium, which
may have a favorable effect on survival as well as LV function [5,6].
Current guidelines recommend that newly diagnosed HF patients
with chest pain be considered for assessment for CAD, which may in-
clude noninvasive imaging or invasive coronary angiography (ICA) [2].
However, the traditional noninvasive modalities that are commonly
used for working up CAD, including echocardiography and nuclear
imaging, are frequently nondiagnostic in the setting of heart failure,
subsequently requiring referral for ICA [7,8]. In turn, ICA can be costly
to patients given its cost and invasiveness, especially for patients in
whom the pretest probability of CAD is low. Also, it is not generally
indicated in patients who are not eligible for coronary revascularization.
Cardiac computed tomographic angiography (CCTA) has been
shown in several large prospective studies to be an effective noninva-
sive modality for ruling out coronary artery disease (CAD) [9–11]. Ine under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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99%, respectively. Thus, CCTA is a promising noninvasive modality to
work up heart failure patients for CAD, and has been deemed in CCTA
guidelines as an appropriate imaging modality for the detection of
CAD in low-to-intermediate pre-test probability patients with reduced
LV systolic function [12]. A few studies support a high sensitivity for
CAD in LV systolic dysfunction [13–15], but they were performed in rel-
atively small single-center populations. There is also concern that the
presence of systolic dysfunction may make CCTA evaluation of CAD
less reliable [16,17].
In this study, our aim was to assess the diagnostic performance of
CCTA to detect coronary artery stenosis in a large multicenter popu-
lation of patients across a wide spectrum of LV function, including a
signiﬁcant number with impaired LVEF, using conventional coronary
angiography as the gold standard.
2. Methods
2.1. Study population
Our study population consisted of patients from 2 separate sources:
(1) the prospectively conducted ACCURACY (Assessment by Coronary
Computed Tomographic Angiography of Individuals Undergoing Inva-
sive Coronary Angiography) trial and (2) a retrospective cohort from a
joint database of CCTA diagnostic procedures performed in two Los
Angeles medical centers between September 2006 and May 2010.
More details regarding the enrollment of patients in the ACCURACY
study population have been described elsewhere [9], but brieﬂy, this
study was designed to prospectively evaluate adult subjects with
chest pain who were being clinically referred for nonemergent ICA
and underwent CCTA as part of the study protocol. Individuals were el-
igible for participation in the ACCURACY study if theywere ≥18 years of
age, experienced typical or atypical chest pain, and were being referred
for nonemergent ICA. Individuals were excluded if they had a
known allergy to iodinated contrast; baseline renal insufﬁciency
(creatinine ≥1.7 mg/dl); irregular cardiac rhythm; resting heart rate
N100 beats/min; resting systolic blood pressure ≤ 100 mm Hg;
contraindication to beta-blocker, calcium-channel blocker, or nitroglyc-
erin; pregnancy; and known history of CAD (prior myocardial
infarction, percutaneous transluminal coronary angioplasty or
intracoronary stent, or coronary artery bypass surgery). The study was
performed at 16 centers in the U.S. For the retrospective cohort, patients
were included in the analysis if they had been referred for diagnostic
work-up of chest pain and had available CCTA and ICA images with
both diagnostic procedures performed no more than 6 months apart.
In addition to the exclusion criteria above, patients were excluded
from analysis if there was no available data on LVEF. LVEF could be
based on either of 4 modalities: CCTA, ICA, nuclear imaging, or
echocardiogram. If LVEF from multiple studies were available for a
given patient, the lowest one was used for analysis.
In the ACCURACY study, the Institutional Review Board at each
participating center had reviewed and approved the study protocol
and patient safety monitoring plan before the study commenced. Pa-
tients in the retrospective cohort gave informed consent to undergo
both diagnostic procedures as part of clinical work-up, andwe obtained
approval from the Institutional Review Board at each center to review
themedical records of these individuals by virtue ofmaintaining patient
records conﬁdentiality.
2.2. CTA protocol and image reconstruction
All CCTA scans were performed with a 64-multidetector row scanner
(GE Healthcare, Milwaukee, WI). Accordingly, data were acquired
with a collimation of 64 × 0.625 mm and a tube rotation time of
350 ms. The tube current was 300–400 mA at 100–120 kV for patients
based on their body size. Individuals presenting with baseline heartrates of N65 beats/min were administered oral beta-blocker therapy
as the preferred method for slowing down the heart rate. Intravenous
administration was allowed in the protocol, using metoprolol at 5 mg
increments to a total possible dose of 25 mg to achieve a resting heart
rate of b65 beats/min.
Following a scout radiograph of the chest (antero-posterior and
lateral), a timing bolus (using 10 to 20 mL contrast) was performed to
detect time to optimal contrast opaciﬁcation in the axial image at a
level immediately superior to the ostium of the left main artery. Nitro-
glycerine 0.4 mg sublingually was administered immediately before
contrast injection. During CCTA acquisition, 60–80 mL iodinated
contrast (depending on the total scan time) was administered
through the antecubital vein at a ﬂow rate of 4 mL/s, followed by a
contrast-saline mixture at 4 mL/s and saline ﬂush at 4 mL/s. Images
were acquired either by using prospective ECG triggering at 75% of
RR interval or by retrospective ECG gating with images constructed
at 5% intervals from5% to95%of RR interval. Subsequently, data setswere
reconstructed and all CCTA images were transferred to 3-dimensional
image analysis workstation (GE Advantage Workstation, GE Healthcare,
Milwaukee, Wisconsin).2.3. Noninvasive multidetector CCTA analysis
Multislice computed tomography examinations were evaluated on
both patient level and vessel level by ≥2 operators (three in the
ACCURACY trial and two in the retrospective cohort). The CCTA readers
were permitted to use any or all of the available post-processing
image reconstruction algorithms, including 2-dimensional axial
and 3-dimensional maximal intensity projection, multiplanar refor-
mat, cross-sectional analysis, and volume rendered technique. CTA
were read in a blindedmanner, independent of invasive angiography
results. The ﬁnal reads were based on core lab reads (consensus
reached between the readers). More detailed information regarding
inter-reader variability with the ACCURACY cohort has been pub-
lished [18].
Coronary arteries were scored using a 15-segment AHA coronary
artery classiﬁcation, as previously described [19]. Coronary artery lu-
minal diameter stenosis was graded as: no stenosis, 1%–29% stenosis,
30%–49% stenosis, 50%–69% stenosis, and ≥70% stenosis by visual
assessment of atherosclerotic lesions using multiple projections
[20]. For each coronary segment, readers assessed whether coronary
segments were evaluable. In the ACCURACY cohort, non-evaluable
segments were assigned stenosis severity based on the outcome of
the most adjacent proximal and identiﬁable segment [9]. In the ret-
rospective cohort, uninterpretable segments (due to motion or colli-
mation artifacts, or severe calciﬁcations) were excluded from further
analysis.2.4. Invasive coronary angiography (ICA)
All patients had conventional ICA performed on the basis of clinical
presentation and/or imaging ﬁndings decided by their cardiologists.
ICAwas performed according to standard clinical protocols [19]. All im-
ages were interpreted by an independent reader blinded to all patients'
characteristics and CCTA results. Multiple projections were acquired to
discern themaximal coronary artery luminal narrowing, andmaximum
stenosis in each vessel was recorded. ICA's were quantitatively evaluat-
ed for coronary artery stenosis with quantitative coronary angiography
software (CAAS, Pie Medical Imaging, Maastricht, the Netherlands).
Coronary artery segments were evaluated using a 15-segment AHA
coronary tree model and were judged as having signiﬁcant stenosis at
2 levels (i.e., if ≥50% or ≥70% luminal diameter stenosis was present).
Coronary segment narrowing was described as: no lesion, b50% steno-
sis, 50%–69% stenosis, and ≥70% stenosis.
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Analysis was performed on per-patient basis, and separately for
≥50% and ≥70% luminal narrowing on CCTA and ICA. A positive ICA or
CCTA was deﬁned as presence of ≥1 coronary artery segment with ob-
structive CAD, and a true positivewas deﬁned as the presence of ≥1 cor-
onary artery segment considered to have an obstructive stenosis by
both CCTA and ICA, irrespective of location. Coronary arteries for data
analysis were deﬁned as follows: (1) left main artery; (2) left anterior
descending artery including the diagonal branches (Ramus Intermedius
arteries were considered to be the ﬁrst diagonal branch for per vessel
analysis); (3) left circumﬂex artery including the obtuse marginal
branches; and (4) right coronary artery inclusive of posterior descend-
ing artery and postero-lateral marginal branch.
2.6. Statistical analysis
The initial analysis was performed for the description of demo-
graphic characteristics in the full study population. In this step, the pa-
tients' LVEF was stratiﬁed by four levels: LVEF b 40, 40 ≤ LVEF b 50,
50 ≤ LVEF b 60, and LVEF ≥ 60. These LVEF cutoffs were chosen based
on commonly used deﬁnitions of reduced/preserved LV systolic func-
tion [21,22]. The ANOVAwas used to assess the linear trend of parame-
ters in these four groups, and post hoc testingwas undertaken using the
Dunnett's multiple comparison test. In the second step, the accuracy of
MDCT angiography in left ventricular systolic dysfunctionwas tested by
calculating the sensitivity, speciﬁcity, accuracy, PPV, and NPV. In the
third step, in order to evaluate the agreement of the diagnoses for pa-
tients withmoderate stenosis (50%–69%) and severe stenosis (blockage
greater than 70%) as well, the kappa coefﬁcient was computed. Differ-
ences were considered to be statistically signiﬁcant when P b 0.05. All
statistical analyses were performed using SAS 9.3 (SAS Institute, Cary,
NC).
3. Results
A total of 537 patients were included in the analysis: 305 with LVEF
≥60%, 150with LVEF 50%–60%, 55with LVEF 40%–50%, and27with LVEF
b40%. 215 of these were from the prospective ACCURACY cohort, while
the remaining 322 were part of the retrospective cohort. The mean age
of the study populationwas 62± 12 years. Eighty-two (15.3%) patients
had left ventricular systolic dysfunction (as deﬁned by LVEF b 50%). In
termsof risk factor proﬁle, therewere statistically signiﬁcant differencesTable 1
Demographic characteristics of study population.
LVEF b 40 40 ≤ LVEF b 50
n= 27 n= 55
Age, years 61.3 ± 12.1 63.0 ± 10.8
Gender
Female 12 (44.4) 19 (34.5)
Male 15 (55.6) 36 (65.5)
BMI, kg/m2 29.4 ± 7.5 29.8 ± 5.3
Race/Ethnic, n (%)
Caucasian 12 (46.2) 30 (63.8)
African American 5 (19.2) 2 (4.3)
Hispanic 6 (23.1) 8 (17.0)
Asian 0 (0.0) 1 (2.1)
Other 3 (11.5) 6 (12.8)
Hyperlipidemia, n (%) 10 (43.5) 37 (67.3)
Family history, n (%) 14 (60.9) 33 (60.0)
Hypertension, n (%) 5 (21.7) 17 (30.9)
Diabetes mellitus, n (%) 6 (26.1) 9 (18.0)
Current smoker, n (%) 3 (13.0) 4 (8.0)
Prevalence N50% stenosis 15 (55.6) 37 (67.3)
Prevalence N70% stenosis 12 (44.4) 29 (52.7)
BMI: body mass index.across groups for hyperlipidemia (highest in 40%–50% cohort), family
history (highest in b40% cohort), diabetesmellitus (highest in ≥60% co-
hort), and current smokers (highest in 50%–60% cohort), although no
particular trend was evident (Table 1). There was no signiﬁcant differ-
ence in terms of prevalence of either ≥50 or ≥70% coronary stenosis
on ICA.
CCTA correctly identiﬁed ≥50% coronary artery stenosis in 50 out of
52 (96.2%) patients with impaired LVEF and 232 out of 237 (97.8%) pa-
tients with normal LVEF; it correctly identiﬁed ≥70% coronary artery
stenosis in 40 (97.6%) out of 41 patients with impaired LVEF and 176
(94.1%) out of 187 patients with normal LVEF. AUC for identiﬁcation of
≥50% stenosis was 0.92 for patients with LVEF b40%, 0.89 in patients
with LVEF 40%–50%, 0.92 in patientswith LVEF 50%–60%, and 0.92 in pa-
tients with LVEF N60%. AUC for identiﬁcation of ≥70% stenosis was 0.97
for patientswith LVEF b40%, 0.91 in patientswith LVEF 40%–50%, 0.93 in
patients with LVEF 50%–60%, and 0.90 in patients with LVEF N60%
(Table 2).
Overall diagnostic accuracy was good, with excellent sensitivity
of 97.6% (95% CI = 95.1–98.8), speciﬁcity of 84.9% (95% CI = 79.9–
88.8), PPV of 88.4% (95% CI = 84.4–91.5), and NPV of 96.7 (95%
CI = 93.4–98.4) to detect 50% stenosis. Accuracy was similarly
good for detecting 70% stenosis, with sensitivity of 94.7% (95%
CI = 91.0–97.0), speciﬁcity of 87.6% (95% CI = 83.4–90.8), PPV of
85.0% (95% CI = 80.1–88.9), and NPV of 95.7 (95% CI = 92.7–97.5).
There was no signiﬁcant difference in sensitivity, speciﬁcity, and
positive or negative predictive values between LVEF cohorts (p for
difference: 0.336 for the detection of stenosis N50% and 0.139 for
the detection of stenosis N70%, respectively). Diagnostic parameters
as stratiﬁed by LVEF are displayed in Tables 2–6.4. Discussion
This is the largest study to date assessing the diagnostic performance
of 64-slice multidetector CCTA to detect coronary artery stenosis across
awide spectrumof LVEF, including a signiﬁcant number of patientswith
LV dysfunction. Our study demonstrated excellent diagnostic accuracy
in heart failure patients, particularly sensitivity and negative predictive
value, as is consistent with prior large prospective trials [9–11]. Most
signiﬁcantly, it did not reveal any signiﬁcant difference between LVEF
cohorts for any of the diagnostic parameters, which suggests that
CCTA accurately detects obstructive CAD regardless of the presence of
systolic dysfunction.50 ≤ LVEF b 60 LVEF ≥ 60 P-value
n= 150 n= 305
61.4 ± 11.8 61.3 ± 12.5 0.82
0.58
68 (45.3) 129 (42.3)
82 (54.7) 176 (57.7)
30.3 ± 5.8 31.1 ± 6.2 0.50
0.11
89 (62.7) 187 (67.3)
7 (4.9) 15 (5.4)
19 (13.4) 24 (8.6)
3 (2.1) 7 (2.5)
24 (16.9) 45 (16.2)
84 (56.8) 146 (50.2) b0.001
68 (45.9) 157 (53.8) 0.02
72 (49.0) 140 (48.3) 0.17
29 (20.1) 88 (30.9) b0.001
24 (16.7) 36 (12.6) 0.006
83 (55.3) 156 (51.1) 0.17
72 (48.0) 116 (38.0) 0.08
Table 2
Accuracy of MDCT angiography in left ventricular systolic dysfunction in full population.
LVEF b 40
(n= 27)
40 ≤ LVEF b 50
(n= 55)
50 ≤ LVEF b 60
(n= 150)
LVEF ≥ 60
(n= 305)
N50% N70% N50% N70% N50% N70% N50% N70%
Sensitivity 100% 100% 94.6% 96.6% 100% 97.2% 96.8% 92.2%
Speciﬁcity 83.3% 93.3% 83.3% 84.6% 83.6% 89.6% 85.9% 86.8%
PPV 88.2% 92.3% 92.1% 87.5% 88.4% 89.6% 87.8% 81.1%
NPV 100% 100% 88.2% 95.7% 100% 97.2% 96.2% 94.8%
LR+ – – 5.68 6.28 – 9.35 6.87 6.97
LR− – – 0.06 0.04 – 0.03 0.04 0.09
AUC 0.92 0.97 0.89 0.91 0.92 0.93 0.92 0.9
PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood
ratio; LR−: negative likelihood ratio; AUC: area under curve.
Table 4
Accuracy of MDCT angiography (40 ≤ LVEF b 50, n= 55).
Stenosis N 50% Stenosis N70%
95%CI 95%CI
Sensitivity 94.6% 0.82, 0.99 96.6% 0.82,0.99
Speciﬁcity 83.3% 0.59, 0.96 84.6% 0.65,0.96
PPV 92.1% 0.79, 0.98 87.5% 0.71,0.96
NPV 88.2% 0.64, 0.99 95.7% 0.78,0.99
LR+ 5.68 2.01, 15.9 6.28 2.54,15.49
LR− 0.06 0.02, 0.25 0.04 0.05,0.28
AUC 0.89 0.79, 0.99 0.91 0.83,0.98
PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood
ratio; LR−: negative likelihood ratio; AUC: area under curve.
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further supports its role as a promising noninvasive modality for the
workup of CAD in heart failure patients. Its high sensitivity and negative
predictive value in heart failure patients make it very effective for
detecting and ruling out CAD, while its relatively high speciﬁcity and
positive predictive value give it a distinctive advantage over ischemia-
driven functional tests, which are relatively sensitive but at best moder-
ately speciﬁc in detecting high-grade coronary stenosis [7,8]. CCTA has
also been shown in other studies to be highly accurate on a per-vessel
basis, thus also allowing it to characterize the extent of CAD and provide
additional prognostic information not given by functional tests [4,9].
Therefore, while conventional ICA remains the gold standard for work-
ing up patients with a high pretest probability of having CAD given the
option to simultaneously revascularize stenotic lesions, CCTA may be
useful in the context of patients with low-to-intermediate pretest prob-
ability of having CAD, especially if traditional noninvasive imaging such
as echocardiogram is nondiagnostic.
Before CCTA can be considered as part of the workup of HF patients,
its risks must be weighed against its beneﬁts. The administration of
nephrotoxic contrast is necessary in both CCTA and invasive angiogra-
phy, although it is a signiﬁcant risk compared to echocardiogram or nu-
clear imaging andmust be consideredwhen choosing between imaging
modalities. The exposure to radiation has traditionally been signiﬁcant-
ly greater in CCTA than ICA, although a growing proportion of CCTA
studies are performed with prospective ECG-gating, which reduces ef-
fective radiation doses by 80% [23] and compares favorably to radioiso-
tope stress perfusion imaging [24] aswell as conventional ICA [25].Most
of the CCTA's in our study were performed with retrospectively gated
helical data acquisition, as the prospective ECG-gated techniquewas in-
troduced fairly recently; however, the image quality of these gating
methods appears to be comparable [26].
There are several limitations of our ﬁndings. First, the study popula-
tion was sampled from two heterogeneous cohorts with a large portion
of data acquired retrospectively, thus implying a substantial risk of
referral, spectrum, and ascertainment bias (non-random selection of
patients being referred for invasive coronary angiography upon CCTATable 3
Accuracy of MDCT angiography (LVEF b 40, n= 27).
Stenosis N 50% Stenosis N70%
95%CI 95%CI
Sensitivity 100% 0.78, 1.0 100% 0.74, 1.0
Speciﬁcity 83.3% 0.52, 0.98 93.3% 0.68, 0.99
PPV 88.2% 0.64, 0.99 92.3% 0.64, 0.99
NPV 100% 0.69, 1.0 100% 0.77, 1.0
LR+ – – – –
LR− – – – –
AUC 0.92 0.81, 1.0 0.97 0.90, 1.0
PPV: positive predictive value; NPV: negative predictive value; LR+: positive likelihood
ratio; LR−: negative likelihood ratio; AUC: area under curve.yielding to higher-than-expected prevalence of CAD). This approach
was taken in order to improve the power of our study and to widen
the applicability of our results to a “real life” population. A different
analysis utilizing the same database of patients showed no signiﬁcant
difference in diagnostic performance of CCTA within the two cohorts,
thus suggesting that bias was in fact minimal [27]. Second, the patients
in our study population were all referred for the workup of chest pain
symptoms. The current guidelines recommend consideration of nonin-
vasive workup of CAD in heart failure patients without chest pain, and
it is not clear how well our results would apply to these patients.
Third, the presence of CAD in a patient with heart failure does not nec-
essarily imply causality of ischemic cardiomyopathy, and should be
assessed in the context of the rest of the patient's clinical and imaging
ﬁndings, such as evidence of priormyocardial infarct. This is a limitation
of invasive catheterization as well as CCTA, although CCTA can also
demonstrate other structural evidence of myocardial infarct [28–30].
In conclusion, 64-multidetector CCTA is very sensitive and fairly
speciﬁc for detecting coronary stenosis in patients with chest pain
regardless of left ventricular systolic function at presentation. In our
study, CCTA was able to detect all patients with CAD and impaired
LVEF, with a sensitivity and negative predictive value of 100% in
this cohort. Thus, CCTA is an excellent ﬁlter for patients with re-
duced ejection fraction to identify those with ischemic cardiomyop-
athy who may beneﬁt from medical anti-ischemic optimization or
revascularization.
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